DZ Bank’s Kyntra Bio KYNB Stock Holding History

DZ Bank’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-800	Closed	-$924K	–	929
2018 Q1	$924K	Buy	+800	New	+$1.05M	﹤0.01%	675

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

DZ Bank's KYNB Position: Q2 2018 in Review

DZ Bank sold out of Kyntra Bio (KYNB) in Q2 2018, closing a stake of 800 shares — an estimated $924K sold.

DZ Bank first reported a position in KYNB in Q1 2018 and held it in 1 quarter. The position peaked at $924K in Q1 2018. 192 funds tracked by Wall St. Rank hold KYNB as of Q2 2018.

DZ Bank reported no remaining Kyntra Bio position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 800 Kyntra Bio shares in Q2 2018, an estimated $924K.
DZ Bank first reported a position in Kyntra Bio in Q1 2018 and held it in 1 quarter.
DZ Bank's Kyntra Bio position peaked at $924K in Q1 2018.
192 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.